A Study to Evaluate U3-1402 in Subjects With Advanced or Metastatic Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Daiichi Sankyo
Related studies linked through entity extraction aliases.
A Study of Quizartinib Pharmacokinetics in Participants With Moderate Hepatic Impairment
- Status
- COMPLETED
- Phase
- PHASE1
A Study in Participants With Advanced Cancers Associated With Expression of DLL3 (MK-6070-001/HPN328-4001)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
What is the Optimal Antithrombotic Strategy in Patients With Atrial Fibrillation Undergoing PCI?
- Status
- RECRUITING
- Phase
- PHASE4
DS-8201a for trEatment of aBc, BRain Mets, And Her2[+] Disease
- Status
- COMPLETED
- Phase
- PHASE2
A Study Evaluating DS-1055a in Participants With Relapsed or Refractory Locally Advanced or Metastatic Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Ph1b/2 Study of the Safety and Efficacy of T-DXd Combinations in Advanced HER2-expressing Gastric Cancer (DESTINY-Gastric03)
- Status
- RECRUITING
- Phase
- PHASE2
Study of Single-dose DS-3201b in Participants With Hepatic Impairment
- Status
- COMPLETED
- Phase
- PHASE1
DS-6157a in Participants With Advanced Gastrointestinal Stromal Tumor (GIST)
- Status
- TERMINATED
- Phase
- PHASE1
HER2-PREDICT: Translational Study of Tumor Samples From Patients Treated With Trastuzumab Deruxtecan (T-DXd; DS-8201a)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
IMPROVE Stroke Care- Developing and Optimizing Regional Systems of Stroke Care
- Status
- COMPLETED
- Phase
- N/A
Study of Pexidartinib in Participants With Moderate Hepatic Impairment Compared With Healthy Participants
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Rotterdam EDOXaban Leaflet Evaluation in Patients After Transcatheter Aortic Valve Implantation
- Status
- UNKNOWN
- Phase
- PHASE3
KEYMAKER-U01 Umbrella Master Study: Studies of Investigational Agents With Either Pembrolizumab (MK-3475) Alone or With Pembrolizumab PLUS Chemotherapy in Participants With Non-small Cell Lung Cancer (NSCLC) (MK-3475-U01/KEYMAKER-U01)
- Status
- RECRUITING
- Phase
- N/A
KEYMAKER-U01 Substudy 01A: Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Chemotherapy When Used With Investigational Agents in Treatment-naïve Participants With Stage IV Non-small Cell Lung Cancer (NSCLC) (MK-3475-01A/KEYMAKER-U01A)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Study of Ifinatamab Deruxtecan (DS-7300a, I-DXd) in Participants With Advanced Solid Malignant Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Trial to Compare Efficacy and Safety of Chemotherapy/Quizartinib vs Chemotherapy/Placebo in Adults FMS-like Tyrosine Kinase 3 (FLT3) Wild-type Acute Myeloid Leukemia (AML)
- Status
- COMPLETED
- Phase
- PHASE2
DS8201a and Pembrolizumab in Participants With Locally Advanced/Metastatic Breast or Non-Small Cell Lung Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Real-life Clinical Outcomes of Direct Oral Anticoagulants (MACACOD)
- Status
- RECRUITING
- Phase
- N/A
Baseline Epidemiologic Assessment of Abuse-Deterrence of MorphaBond Extended Release (BEAD-MB)
- Status
- COMPLETED
- Phase
- N/A